Which peptides are studied in relation to skin hydration?
A research-supply review of peptides and related actives investigated for skin hydration, covering collagen tripeptide, AP collagen peptide, fish collagen hydrolysates, L-carnosine, pentapeptide-18, and ergothioneine, wi
The peptides most frequently studied in relation to skin hydration are collagen-derived peptides, including collagen tripeptide (CTP) and AP collagen peptide (APCP), fish collagen hydrolysates, and the dipeptide L-carnosine (beta-alanyl-L-histidine). Related actives studied in the same context include the amino acid derivative ergothioneine and the synthetic pentapeptide-18. Collagen peptides are short amino acid chains produced by hydrolysis of parent collagen; they are characterised by low antigenicity and are used as dietary or topical research materials [2][3][4]. L-Carnosine is a naturally occurring dipeptide composed of beta-alanine and L-histidine, and it has been investigated in a hyaluronate-containing injectable formulation for facial skin hydration and brightness [5].
The mechanistic work in this area centres on extracellular matrix (ECM) biology and epidermal barrier function, with collagen peptide studies examining dermal matrix synthesis and barrier-related water loss, and carnosine studies examining oxidative and glycation-related pathways in the skin [4][5][11].
Research Studies
AP collagen peptide and skin hydration in a mouse model of oxazolone-induced atopic dermatitis
AP collagen peptide (APCP), which contains collagen tripeptide, was evaluated in an oxazolone (OXZ)-induced atopic dermatitis-like model using hairless mice. The study measured skin hydration and transepidermal water loss (TEWL) alongside inflammatory responses. The authors noted that CTP has been reported to improve skin hydration and barrier function, but that its effects in atopic dermatitis, particularly under barrier dysfunction, had not been fully established [2]. This is an animal model; findings in hairless mice do not establish effects in humans.
Collagen tripeptide and barrier function in atopic dermatitis research
Collagen tripeptide is described in the APCP study as an amino acid-rich dietary supplement with low antigenicity. The same paper frames atopic dermatitis as a chronic relapsing inflammatory disorder with impaired skin barrier function and Th2-mediated immune responses, and positions CTP within that barrier-focused research context [2]. The evidence for CTP in this setting comes from the mouse model described above, not from controlled human trials.
Fish collagen hydrolysates and wound healing in a patent review
A patent review of fish collagen hydrolysates in wound healing describes collagen peptides derived from collagen hydrolysis as bioactive materials of interest for advanced dressings. Fish collagen has gained prominence due to its favourable profile compared with traditional sources. The review situates these peptides in the context of wound healing, a process that can be delayed by bacterial contamination, dressing irritation, and internal conditions such as diabetes [3]. This is a review of patent literature, not a clinical efficacy study.
Oral collagen peptides and skin hydration in human evidence
A narrative review evaluated human evidence on oral collagen supplementation for skin, hair, nails, and wound healing. It describes collagen as a key structural protein of the skin, essential for mechanical strength, elasticity, and hydration, and notes that oral collagen peptides have gained interest as a nutritional strategy. The review characterises the evidence as heterogeneous [4]. The heterogeneity is the finding: human studies in this area do not converge on a single consistent result.
L-Carnosine in a hyaluronate injection and facial skin hydration
A randomized, controlled, evaluator-blinded trial assessed the efficacy and safety of an L-carnosine-containing hyaluronate injection for facial skin hydration and brightness [5]. This is a clinical study in human subjects; the intervention is an injectable formulation, not an oral or topical research peptide.
Ergothioneine and skin hydration outcomes in a registered trial
A randomized, double-blind, placebo-controlled trial is evaluating NVTIA ergothioneine, a branded ergothioneine ingredient, in healthy adults aged 40 to 65 years. Participants receive the ingredient or matching placebo once daily for 12 weeks. The primary objective is to evaluate effects on biomarkers associated with oxidative stress and healthy aging; secondary objectives include skin elasticity, skin hydration, inflammatory biomarkers, and overall safety [1]. This is a registered trial; results are not yet reported in the evidence provided.
Pentapeptide-18 and extracellular matrix interaction analysis
Pentapeptide-18 has been characterised spectroscopically and analysed for molecular interactions as an anti-aging candidate. The work frames skin aging as progressive breakdown of the dermal extracellular matrix, leading to wrinkle development from repetitive facial muscle movements and gradual reduction in collagen and elastin synthesis [11]. This is a characterisation and interaction study, not a hydration trial.
Comparison of peptide and non-peptide actives studied for hydration
Several non-peptide actives appear in the same hydration literature and are useful comparators when reading peptide studies. The table below summarises the model systems and reported focus of each.
| Active | Class | Model or population | Reported focus |
|---|---|---|---|
| AP collagen peptide (contains CTP) | Collagen peptide | Hairless mice, oxazolone-induced AD-like model | Skin hydration, TEWL, inflammatory responses [2] |
| Fish collagen hydrolysates | Collagen peptide | Patent literature review | Wound healing dressings [3] |
| Oral collagen peptides | Collagen peptide | Human evidence, narrative review | Skin, hair, nails, wound healing; heterogeneous evidence [4] |
| L-Carnosine | Dipeptide | Human, randomized controlled evaluator-blinded trial | Facial skin hydration and brightness, injectable hyaluronate formulation [5] |
| Ergothioneine (NVTIA) | Amino acid derivative | Healthy adults 40–65, registered RCT | Oxidative stress and aging biomarkers; secondary skin hydration [1] |
| Pentapeptide-18 | Synthetic pentapeptide | Spectroscopic and molecular interaction analysis | Dermal ECM breakdown, collagen and elastin synthesis [11] |
| Panthenol, niacinamide, dipotassium glycyrrhizate | Non-peptide topical formulation | Human, randomized split-leg trial in xerosis | Skin hydration and barrier function [6] |
Topical non-peptide formulation and barrier function in xerosis
A randomized, intra-individual, split-leg trial evaluated a topical formulation containing panthenol, niacinamide, and dipotassium glycyrrhizate in subjects with xerosis cutis. Subjects applied the emollient twice daily for 28 days to one pretibial area, with the contralateral leg untreated as control. Assessments covered efficacy, tolerability, and subjective perception in dry, sensitive skin [6]. This study is included because it defines the clinical hydration and barrier endpoints against which peptide research is often read.
PDGF-related topical solution after ablative laser
A post-market cosmetic evaluation is assessing Ariessence Pure PDGF+, a viscous leave-on topical solution intended for use after non-medical cosmetic procedures performed by licensed healthcare professionals, to enhance comfort and maintain skin hydration. The study applies the product to the full face after an ablative laser procedure and compares it with an emollient control, evaluating procedure tolerability and appearance of the skin [7]. This is a cosmetic evaluation, not a peptide hydration trial.
Hyaluronate skinbooster with L-carnitine and vitamin C
A post-market clinical investigation is evaluating Cellbooster Shape, a CE-marked hyaluronic acid-based superficial epidermis/dermis injection filler and skinbooster produced with CHAC Technology. It consists of non-crosslinked HA with L-carnitine and vitamin C and is designed for reducing local puffiness by improving microcirculation and hydration. Healthy subjects with signs of facial skin aging receive a 3-session treatment with follow-up over 70 days after the initial injection session [8]. This is a device study, not a peptide study.
Hydrogel facial mask in sensitive skin
A pilot study investigated the safety, tolerability, and functional performance of a hydrogel facial mask based on poly(N-vinyl pyrrolidone) and poly(ethylene glycol) in sensitive skin, examining long-term effects on hydration, barrier function, and mechanical properties [10]. This is a device-format study rather than a peptide study.
Niacinamide soft matter systems and formulation stability
A formulation study developed a structurally stable skin-brightening moisturizing cream using hydroxyethyl cellulose as a functional polymer additive with niacinamide as the active ingredient, systematically examining physicochemical properties and performance [9]. This work addresses formulation behaviour rather than peptide hydration mechanisms.
Combination mesotherapy for facial photoaging
A retrospective study reported clinical outcomes of intense pulsed light combined with non-crosslinked sodium hyaluronate, tranexamic acid, and vitamin C mesotherapy for facial photoaging. The authors note that facial photoaging involves structural and functional deterioration across multiple skin layers and that single-modality treatments rarely address pigmentary, vascular, and dermal matrix changes concurrently [12]. This is a combination-device study, not a peptide study.
If you are reading this for personal health reasons
The materials described here are sold for laboratory research use only. We do not provide dosing, medical guidance, or recommendations for personal use. Anyone considering a compound for themselves should speak to a licensed clinician.
Sources
- [1] NVTIA Ergothioneine for Healthy Aging and Skin Health — https://clinicaltrials.gov/study/NCT07750002
- [2] Potential Supportive Effects of AP Collagen Peptides on Skin Hydration in a Mouse Model of Oxazolone-Induced Atopic Dermatitis — https://europepmc.org/article/PMC/PMC13526892
- [3] Fish Collagen Hydrolysates in Wound Healing: A Patent Review — https://europepmc.org/article/PMC/PMC13482881
- [4] Dietary Collagen Supplementation as a Strategy for Skin Health: A Narrative Review of Clinical Effects on Skin, Hair, Nails, and Wound Healing — https://europepmc.org/article/PMC/PMC13364118
- [5] Efficacy and Safety of L-Carnosine-Containing Hyaluronate Injection for Facial Skin Hydration and Brightness: A Randomized, Controlled, Evaluator-Blinded Trial — https://europepmc.org/article/PMC/PMC13323873
- [6] Efficacy of a Topical Formulation on Skin Hydration and Barrier Function in Individuals With Xerosis: A 28-Day Randomized, Split-Leg, Untreated-Controlled Trial — https://europepmc.org/article/PMC/PMC13158435
- [7] Post-market Cosmetic Evaluation of Ariessence Pure PDGF+ Following Ablative Laser — https://clinicaltrials.gov/study/NCT07718347
- [8] Effectiveness and Safety of Cellbooster Shape in Healthy Subjects — https://clinicaltrials.gov/study/NCT07636512
- [9] Intermolecular network reorganization induced by hydroxyethyl cellulose enables structurally stable niacinamide-based soft matter systems — https://pubmed.ncbi.nlm.nih.gov/42595163/
- [10] Hydrogel facial mask for sensitive skin: A pilot study of long-term effects on hydration, barrier function and mechanical properties — https://europepmc.org/article/PMC/PMC13448365
- [11] Pentapeptide-18 as an anti-aging candidate: Spectroscopic characterization and molecular interaction analysis — https://pubmed.ncbi.nlm.nih.gov/41722287/
- [12] Clinical outcomes of intense pulsed light combined with non-crosslinked sodium hyaluronate, tranexamic acid, and vitamin C mesotherapy for facial photoaging: a retrospective study — https://pubmed.ncbi.nlm.nih.gov/41489066/